Gilead Sciences gilead.com

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancerutilized proprietary "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds. Gilead's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancerutilized proprietary "combinatorial chemistry" technology to discover lead therapeuti...Show all

See All Exits Recent Exits

Phone: 650-574-3000

Fax:

333 Lakeside Drive

 Foster City, 94404
 California, United States

Gilead Sciences - Investments & Acquisitions

Show Real Data Gilead Sciences Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-10-31Tango TherapeuticsMilestone Payment$50M
2018-08-06Glympse BioSeries A$22MARCH Venture Partners, Aspect Ventures, CRV, GreatPoint Ventures, Heritage Provider Network, Inevitable Ventures, Polaris Partners, Rivas Capital, and Yonghua Capital
2018-07-19GadetaAcquired
2018-06-08Precision BioSciencesSeries B$110MAdage Capital Management, Agent Capital, Alexandria Venture Investments, Amgen Ventures, ArrowMark Partners, Brace Pharma Capital, Cormorant Asset Management, Cowen Group, DUMAC, F-Prime Capital, Franklin Templeton Investments, Leerink Partners, OCV Partners, Osage University Partners, Pontifax AgTech, RA Capital Management, Ridgeback Capital Management, The Longevity Fund, venBIO, and Vivo Capital
2018-01-03Tmunity TherapeuticsSeries A$100MBe The Match BioTherapies, Lilly Asia Ventures, Parker Institute for Cancer Immunotherapy, Ping An Ventures, and University of Pennsylvania
See all 5 investments